FDA Approves Lusutrombopag for Thrombocytopenia in Adults with Chronic Liver Disease
Jul 31
2018
The Food and Drug Administration approved lusutrombopag (Mulpleta, Shionogi Inc.) for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure.
